| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | +41.9% | +39.4% |
| Cost of Revenue | $1.7M | +13.2% | +18.8% |
| Gross Profit | $864K | +176.0% | +108.7% |
| R&D Expense | $3.6M | -5.2% | -7.2% |
| SG&A Expense | $5.9M | +10.6% | +68.8% |
| Operating Income | -$13.1M | -0.2% | -54.2% |
| Net Income | -$12.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.4M | +450.9% | +300.8% |
| Short-term Investments | $15.7M | +99.9% | -36.1% |
| Accounts Receivable | $2.0M | +23.2% | +28.2% |
| Inventory | $3.6M | +18.1% | +47.5% |
| Current Assets | $70.4M | +176.4% | +51.7% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.8M | — | — |
| Capital Expenditures | $1.3M | — | — |
| Investing Cash Flow | $14.6M | — | — |
| Financing Cash Flow | $55.6M | — | — |
| Free Cash Flow | -$27.0M | — | — |
| +3.4% |
| -61.1% |
| EPS (Basic) | -$0.17 | +34.6% | -6.3% |
| EPS (Diluted) | -$0.17 | +34.6% | -6.3% |
| $78.5M |
| +135.4% |
| +55.4% |
| Current Liabilities | $10.8M | +19.3% | +48.9% |
| Total Liabilities | $14.4M | +9.6% | +57.3% |
| Stockholders' Equity | $64.1M | +216.7% | +55.0% |